ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Disease Biomarker Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-27S7874
Home | Market Reports | Health| Nursing
Global Infectious Disease Biomarker Testing Market Insights Forecast to 2028
BUY CHAPTERS

Global Infectious Disease Biomarker Testing Market Research Report 2025

Code: QYRE-Auto-27S7874
Report
September 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
BioMérieux SA
Bio Rad Laboratories
Danaher
F.Hoffmann-La Roche
Hologic Inc
PerkinElmer Inc
Qiagen NV
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific

Infectious Disease Biomarker Testing Market

The global market for Infectious Disease Biomarker Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Infectious Disease Biomarker Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Infectious Disease Biomarker Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Infectious Disease Biomarker Testing in Hospitals and Clinics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Infectious Disease Biomarker Testing include Abacus Diagnostica, ALPCO, Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Biomarker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Biomarker Testing.
The Infectious Disease Biomarker Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Disease Biomarker Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Biomarker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Infectious Disease Biomarker Testing Market Report

Report Metric Details
Report Name Infectious Disease Biomarker Testing Market
Segment by Type
  • PCR
  • NGS
  • ELISA or EIA
  • IHC
  • ISH
  • Others
Segment by Application
  • Hospitals and Clinics
  • Diagnostic Centers
  • Academic Research Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abacus Diagnostica, ALPCO, Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Hologic, PerkinElmer, Qiagen, Quest Diagnostics Incorporated, Siemens Healthineers, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Infectious Disease Biomarker Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Infectious Disease Biomarker Testing Market report?

Ans: The main players in the Infectious Disease Biomarker Testing Market are Abacus Diagnostica, ALPCO, Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Hologic, PerkinElmer, Qiagen, Quest Diagnostics Incorporated, Siemens Healthineers, Thermo Fisher Scientific

What are the Application segmentation covered in the Infectious Disease Biomarker Testing Market report?

Ans: The Applications covered in the Infectious Disease Biomarker Testing Market report are Hospitals and Clinics, Diagnostic Centers, Academic Research Institutes, Others

What are the Type segmentation covered in the Infectious Disease Biomarker Testing Market report?

Ans: The Types covered in the Infectious Disease Biomarker Testing Market report are PCR, NGS, ELISA or EIA, IHC, ISH, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Biomarker Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 NGS
1.2.4 ELISA or EIA
1.2.5 IHC
1.2.6 ISH
1.2.7 Others
1.3 Market by Application
1.3.1 Global Infectious Disease Biomarker Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Academic Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Biomarker Testing Market Perspective (2020-2031)
2.2 Global Infectious Disease Biomarker Testing Growth Trends by Region
2.2.1 Global Infectious Disease Biomarker Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Infectious Disease Biomarker Testing Historic Market Size by Region (2020-2025)
2.2.3 Infectious Disease Biomarker Testing Forecasted Market Size by Region (2026-2031)
2.3 Infectious Disease Biomarker Testing Market Dynamics
2.3.1 Infectious Disease Biomarker Testing Industry Trends
2.3.2 Infectious Disease Biomarker Testing Market Drivers
2.3.3 Infectious Disease Biomarker Testing Market Challenges
2.3.4 Infectious Disease Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Biomarker Testing Players by Revenue
3.1.1 Global Top Infectious Disease Biomarker Testing Players by Revenue (2020-2025)
3.1.2 Global Infectious Disease Biomarker Testing Revenue Market Share by Players (2020-2025)
3.2 Global Infectious Disease Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Infectious Disease Biomarker Testing Revenue
3.4 Global Infectious Disease Biomarker Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Biomarker Testing Revenue in 2024
3.5 Global Key Players of Infectious Disease Biomarker Testing Head office and Area Served
3.6 Global Key Players of Infectious Disease Biomarker Testing, Product and Application
3.7 Global Key Players of Infectious Disease Biomarker Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Biomarker Testing Breakdown Data by Type
4.1 Global Infectious Disease Biomarker Testing Historic Market Size by Type (2020-2025)
4.2 Global Infectious Disease Biomarker Testing Forecasted Market Size by Type (2026-2031)
5 Infectious Disease Biomarker Testing Breakdown Data by Application
5.1 Global Infectious Disease Biomarker Testing Historic Market Size by Application (2020-2025)
5.2 Global Infectious Disease Biomarker Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Infectious Disease Biomarker Testing Market Size (2020-2031)
6.2 North America Infectious Disease Biomarker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Infectious Disease Biomarker Testing Market Size by Country (2020-2025)
6.4 North America Infectious Disease Biomarker Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Biomarker Testing Market Size (2020-2031)
7.2 Europe Infectious Disease Biomarker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Infectious Disease Biomarker Testing Market Size by Country (2020-2025)
7.4 Europe Infectious Disease Biomarker Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Biomarker Testing Market Size (2020-2031)
8.2 Asia-Pacific Infectious Disease Biomarker Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Biomarker Testing Market Size (2020-2031)
9.2 Latin America Infectious Disease Biomarker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Infectious Disease Biomarker Testing Market Size by Country (2020-2025)
9.4 Latin America Infectious Disease Biomarker Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Biomarker Testing Market Size (2020-2031)
10.2 Middle East & Africa Infectious Disease Biomarker Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abacus Diagnostica
11.1.1 Abacus Diagnostica Company Details
11.1.2 Abacus Diagnostica Business Overview
11.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Introduction
11.1.4 Abacus Diagnostica Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.1.5 Abacus Diagnostica Recent Development
11.2 ALPCO
11.2.1 ALPCO Company Details
11.2.2 ALPCO Business Overview
11.2.3 ALPCO Infectious Disease Biomarker Testing Introduction
11.2.4 ALPCO Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.2.5 ALPCO Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Introduction
11.3.4 Abbott Laboratories Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.3.5 Abbott Laboratories Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Infectious Disease Biomarker Testing Introduction
11.4.4 Agilent Technologies Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 Becton
11.5.1 Becton Company Details
11.5.2 Becton Business Overview
11.5.3 Becton Infectious Disease Biomarker Testing Introduction
11.5.4 Becton Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.5.5 Becton Recent Development
11.6 Dickinson and Company
11.6.1 Dickinson and Company Company Details
11.6.2 Dickinson and Company Business Overview
11.6.3 Dickinson and Company Infectious Disease Biomarker Testing Introduction
11.6.4 Dickinson and Company Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.6.5 Dickinson and Company Recent Development
11.7 bioMérieux SA
11.7.1 bioMérieux SA Company Details
11.7.2 bioMérieux SA Business Overview
11.7.3 bioMérieux SA Infectious Disease Biomarker Testing Introduction
11.7.4 bioMérieux SA Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.7.5 bioMérieux SA Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Introduction
11.8.4 Bio-Rad Laboratories Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Danaher
11.9.1 Danaher Company Details
11.9.2 Danaher Business Overview
11.9.3 Danaher Infectious Disease Biomarker Testing Introduction
11.9.4 Danaher Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.9.5 Danaher Recent Development
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Details
11.10.2 F. Hoffmann-La Roche Business Overview
11.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Introduction
11.10.4 F. Hoffmann-La Roche Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.10.5 F. Hoffmann-La Roche Recent Development
11.11 Hologic
11.11.1 Hologic Company Details
11.11.2 Hologic Business Overview
11.11.3 Hologic Infectious Disease Biomarker Testing Introduction
11.11.4 Hologic Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.11.5 Hologic Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Details
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Infectious Disease Biomarker Testing Introduction
11.12.4 PerkinElmer Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.12.5 PerkinElmer Recent Development
11.13 Qiagen
11.13.1 Qiagen Company Details
11.13.2 Qiagen Business Overview
11.13.3 Qiagen Infectious Disease Biomarker Testing Introduction
11.13.4 Qiagen Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.13.5 Qiagen Recent Development
11.14 Quest Diagnostics Incorporated
11.14.1 Quest Diagnostics Incorporated Company Details
11.14.2 Quest Diagnostics Incorporated Business Overview
11.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Introduction
11.14.4 Quest Diagnostics Incorporated Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.14.5 Quest Diagnostics Incorporated Recent Development
11.15 Siemens Healthineers
11.15.1 Siemens Healthineers Company Details
11.15.2 Siemens Healthineers Business Overview
11.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Introduction
11.15.4 Siemens Healthineers Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.15.5 Siemens Healthineers Recent Development
11.16 Thermo Fisher Scientific
11.16.1 Thermo Fisher Scientific Company Details
11.16.2 Thermo Fisher Scientific Business Overview
11.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Introduction
11.16.4 Thermo Fisher Scientific Revenue in Infectious Disease Biomarker Testing Business (2020-2025)
11.16.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
BioMérieux SA
Bio Rad Laboratories
Danaher
F.Hoffmann-La Roche
Hologic Inc
PerkinElmer Inc
Qiagen NV
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific
List of Tables
 Table 1. Global Infectious Disease Biomarker Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of PCR
 Table 3. Key Players of NGS
 Table 4. Key Players of ELISA or EIA
 Table 5. Key Players of IHC
 Table 6. Key Players of ISH
 Table 7. Key Players of Others
 Table 8. Global Infectious Disease Biomarker Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Infectious Disease Biomarker Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Infectious Disease Biomarker Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Infectious Disease Biomarker Testing Market Share by Region (2020-2025)
 Table 12. Global Infectious Disease Biomarker Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Infectious Disease Biomarker Testing Market Share by Region (2026-2031)
 Table 14. Infectious Disease Biomarker Testing Market Trends
 Table 15. Infectious Disease Biomarker Testing Market Drivers
 Table 16. Infectious Disease Biomarker Testing Market Challenges
 Table 17. Infectious Disease Biomarker Testing Market Restraints
 Table 18. Global Infectious Disease Biomarker Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Infectious Disease Biomarker Testing Market Share by Players (2020-2025)
 Table 20. Global Top Infectious Disease Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Biomarker Testing as of 2024)
 Table 21. Ranking of Global Top Infectious Disease Biomarker Testing Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Infectious Disease Biomarker Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Infectious Disease Biomarker Testing, Headquarters and Area Served
 Table 24. Global Key Players of Infectious Disease Biomarker Testing, Product and Application
 Table 25. Global Key Players of Infectious Disease Biomarker Testing, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Infectious Disease Biomarker Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Infectious Disease Biomarker Testing Revenue Market Share by Type (2020-2025)
 Table 29. Global Infectious Disease Biomarker Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Infectious Disease Biomarker Testing Revenue Market Share by Type (2026-2031)
 Table 31. Global Infectious Disease Biomarker Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Infectious Disease Biomarker Testing Revenue Market Share by Application (2020-2025)
 Table 33. Global Infectious Disease Biomarker Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Infectious Disease Biomarker Testing Revenue Market Share by Application (2026-2031)
 Table 35. North America Infectious Disease Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Infectious Disease Biomarker Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Infectious Disease Biomarker Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Infectious Disease Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Infectious Disease Biomarker Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Infectious Disease Biomarker Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Infectious Disease Biomarker Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Infectious Disease Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Infectious Disease Biomarker Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Infectious Disease Biomarker Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Infectious Disease Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Abacus Diagnostica Company Details
 Table 51. Abacus Diagnostica Business Overview
 Table 52. Abacus Diagnostica Infectious Disease Biomarker Testing Product
 Table 53. Abacus Diagnostica Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 54. Abacus Diagnostica Recent Development
 Table 55. ALPCO Company Details
 Table 56. ALPCO Business Overview
 Table 57. ALPCO Infectious Disease Biomarker Testing Product
 Table 58. ALPCO Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 59. ALPCO Recent Development
 Table 60. Abbott Laboratories Company Details
 Table 61. Abbott Laboratories Business Overview
 Table 62. Abbott Laboratories Infectious Disease Biomarker Testing Product
 Table 63. Abbott Laboratories Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 64. Abbott Laboratories Recent Development
 Table 65. Agilent Technologies Company Details
 Table 66. Agilent Technologies Business Overview
 Table 67. Agilent Technologies Infectious Disease Biomarker Testing Product
 Table 68. Agilent Technologies Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 69. Agilent Technologies Recent Development
 Table 70. Becton Company Details
 Table 71. Becton Business Overview
 Table 72. Becton Infectious Disease Biomarker Testing Product
 Table 73. Becton Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 74. Becton Recent Development
 Table 75. Dickinson and Company Company Details
 Table 76. Dickinson and Company Business Overview
 Table 77. Dickinson and Company Infectious Disease Biomarker Testing Product
 Table 78. Dickinson and Company Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 79. Dickinson and Company Recent Development
 Table 80. bioMérieux SA Company Details
 Table 81. bioMérieux SA Business Overview
 Table 82. bioMérieux SA Infectious Disease Biomarker Testing Product
 Table 83. bioMérieux SA Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 84. bioMérieux SA Recent Development
 Table 85. Bio-Rad Laboratories Company Details
 Table 86. Bio-Rad Laboratories Business Overview
 Table 87. Bio-Rad Laboratories Infectious Disease Biomarker Testing Product
 Table 88. Bio-Rad Laboratories Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 89. Bio-Rad Laboratories Recent Development
 Table 90. Danaher Company Details
 Table 91. Danaher Business Overview
 Table 92. Danaher Infectious Disease Biomarker Testing Product
 Table 93. Danaher Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 94. Danaher Recent Development
 Table 95. F. Hoffmann-La Roche Company Details
 Table 96. F. Hoffmann-La Roche Business Overview
 Table 97. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product
 Table 98. F. Hoffmann-La Roche Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 99. F. Hoffmann-La Roche Recent Development
 Table 100. Hologic Company Details
 Table 101. Hologic Business Overview
 Table 102. Hologic Infectious Disease Biomarker Testing Product
 Table 103. Hologic Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 104. Hologic Recent Development
 Table 105. PerkinElmer Company Details
 Table 106. PerkinElmer Business Overview
 Table 107. PerkinElmer Infectious Disease Biomarker Testing Product
 Table 108. PerkinElmer Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 109. PerkinElmer Recent Development
 Table 110. Qiagen Company Details
 Table 111. Qiagen Business Overview
 Table 112. Qiagen Infectious Disease Biomarker Testing Product
 Table 113. Qiagen Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 114. Qiagen Recent Development
 Table 115. Quest Diagnostics Incorporated Company Details
 Table 116. Quest Diagnostics Incorporated Business Overview
 Table 117. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product
 Table 118. Quest Diagnostics Incorporated Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 119. Quest Diagnostics Incorporated Recent Development
 Table 120. Siemens Healthineers Company Details
 Table 121. Siemens Healthineers Business Overview
 Table 122. Siemens Healthineers Infectious Disease Biomarker Testing Product
 Table 123. Siemens Healthineers Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 124. Siemens Healthineers Recent Development
 Table 125. Thermo Fisher Scientific Company Details
 Table 126. Thermo Fisher Scientific Business Overview
 Table 127. Thermo Fisher Scientific Infectious Disease Biomarker Testing Product
 Table 128. Thermo Fisher Scientific Revenue in Infectious Disease Biomarker Testing Business (2020-2025) & (US$ Million)
 Table 129. Thermo Fisher Scientific Recent Development
 Table 130. Research Programs/Design for This Report
 Table 131. Key Data Information from Secondary Sources
 Table 132. Key Data Information from Primary Sources
 Table 133. Authors List of This Report


List of Figures
 Figure 1. Infectious Disease Biomarker Testing Picture
 Figure 2. Global Infectious Disease Biomarker Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Infectious Disease Biomarker Testing Market Share by Type: 2024 VS 2031
 Figure 4. PCR Features
 Figure 5. NGS Features
 Figure 6. ELISA or EIA Features
 Figure 7. IHC Features
 Figure 8. ISH Features
 Figure 9. Others Features
 Figure 10. Global Infectious Disease Biomarker Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Infectious Disease Biomarker Testing Market Share by Application: 2024 VS 2031
 Figure 12. Hospitals and Clinics Case Studies
 Figure 13. Diagnostic Centers Case Studies
 Figure 14. Academic Research Institutes Case Studies
 Figure 15. Others Case Studies
 Figure 16. Infectious Disease Biomarker Testing Report Years Considered
 Figure 17. Global Infectious Disease Biomarker Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Infectious Disease Biomarker Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Infectious Disease Biomarker Testing Market Share by Region: 2024 VS 2031
 Figure 20. Global Infectious Disease Biomarker Testing Market Share by Players in 2024
 Figure 21. Global Top Infectious Disease Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Biomarker Testing as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Infectious Disease Biomarker Testing Revenue in 2024
 Figure 23. North America Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Infectious Disease Biomarker Testing Market Share by Country (2020-2031)
 Figure 25. United States Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Infectious Disease Biomarker Testing Market Share by Country (2020-2031)
 Figure 29. Germany Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Infectious Disease Biomarker Testing Market Share by Region (2020-2031)
 Figure 37. China Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Infectious Disease Biomarker Testing Market Share by Country (2020-2031)
 Figure 45. Mexico Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Infectious Disease Biomarker Testing Market Share by Country (2020-2031)
 Figure 49. Turkey Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Infectious Disease Biomarker Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Abacus Diagnostica Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 53. ALPCO Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 54. Abbott Laboratories Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 55. Agilent Technologies Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 56. Becton Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 57. Dickinson and Company Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 58. bioMérieux SA Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 60. Danaher Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 62. Hologic Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 63. PerkinElmer Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 64. Qiagen Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 65. Quest Diagnostics Incorporated Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 66. Siemens Healthineers Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Infectious Disease Testing And Diagnostic Market Research Report 2024
Global Infectious Disease Testing Instrumentation Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Infectious Disease In Vitro Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Infectious Diseases Molecular Diagnostics Market Research Report 2025
Healthcare associated Infectious Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tumor Biomarker Test Market Research Report 2024
Global Infectious Disease Clinical Trials Market Research Report 2025
Global Genomic Biomarkers Market Research Report 2024
Global Alzheimer s Disease Biomarker Market Research Report 2024
Point of Care Testing for Infectious Disease Market
Infectious Disease Rapid Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Stool Biomarkers Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Imaging Biomarker Market Research Report 2025
Global Biomarker POCT Market Research Report 2024
Global Cardiac Biomarkers Testing Device Market Research Report 2025
Global Tuberculosis Infection Testing Market Research Report 2024
Global Pathogen Microbiological Testing of Water Market Research Report 2025
Global Bioassay Testing Market Research Report 2025
Global Blood Infection Testing Market Research Report 2024
Global Anti microbial Tests Market Research Report 2024

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions